260 related articles for article (PubMed ID: 22027006)
1. Novel vaginal microflora colonization model providing new insight into microbicide mechanism of action.
Fichorova RN; Yamamoto HS; Delaney ML; Onderdonk AB; Doncel GF
mBio; 2011; 2(6):e00168-11. PubMed ID: 22027006
[TBL] [Abstract][Full Text] [Related]
2. Bacteria in the vaginal microbiome alter the innate immune response and barrier properties of the human vaginal epithelia in a species-specific manner.
Doerflinger SY; Throop AL; Herbst-Kralovetz MM
J Infect Dis; 2014 Jun; 209(12):1989-99. PubMed ID: 24403560
[TBL] [Abstract][Full Text] [Related]
3. Toward early safety alert endpoints: exploring biomarkers suggestive of microbicide failure.
Mauck CK; Lai JJ; Weiner DH; Chandra N; Fichorova RN; Dezzutti CS; Hillier SL; Archer DF; Creinin MD; Schwartz JL; Callahan MM; Doncel GF
AIDS Res Hum Retroviruses; 2013 Nov; 29(11):1475-86. PubMed ID: 23885658
[TBL] [Abstract][Full Text] [Related]
4. Effects of bacterial vaginosis-associated bacteria and sexual intercourse on vaginal colonization with the probiotic Lactobacillus crispatus CTV-05.
Ngugi BM; Hemmerling A; Bukusi EA; Kikuvi G; Gikunju J; Shiboski S; Fredricks DN; Cohen CR
Sex Transm Dis; 2011 Nov; 38(11):1020-7. PubMed ID: 21992977
[TBL] [Abstract][Full Text] [Related]
5. Twice-daily application of HIV microbicides alter the vaginal microbiota.
Ravel J; Gajer P; Fu L; Mauck CK; Koenig SS; Sakamoto J; Motsinger-Reif AA; Doncel GF; Zeichner SL
mBio; 2012 Dec; 3(6):. PubMed ID: 23249810
[TBL] [Abstract][Full Text] [Related]
6. The villain team-up or how Trichomonas vaginalis and bacterial vaginosis alter innate immunity in concert.
Fichorova RN; Buck OR; Yamamoto HS; Fashemi T; Dawood HY; Fashemi B; Hayes GR; Beach DH; Takagi Y; Delaney ML; Nibert ML; Singh BN; Onderdonk AB
Sex Transm Infect; 2013 Sep; 89(6):460-6. PubMed ID: 23903808
[TBL] [Abstract][Full Text] [Related]
7. The lower genital tract microbiota in relation to cytokine-, SLPI- and endotoxin levels: application of checkerboard DNA-DNA hybridization (CDH).
Nikolaitchouk N; Andersch B; Falsen E; Strömbeck L; Mattsby-Baltzer I
APMIS; 2008 Apr; 116(4):263-77. PubMed ID: 18397461
[TBL] [Abstract][Full Text] [Related]
8. Homeostatic properties of Lactobacillus jensenii engineered as a live vaginal anti-HIV microbicide.
Yamamoto HS; Xu Q; Fichorova RN
BMC Microbiol; 2013 Jan; 13():4. PubMed ID: 23298379
[TBL] [Abstract][Full Text] [Related]
9. Temporal Changes in Vaginal Microbiota and Genital Tract Cytokines Among South African Women Treated for Bacterial Vaginosis.
Mtshali A; San JE; Osman F; Garrett N; Balle C; Giandhari J; Onywera H; Mngomezulu K; Mzobe G; de Oliveira T; Rompalo A; Mindel A; Abdool Karim SS; Ravel J; Passmore JS; Abdool Karim Q; Jaspan HB; Liebenberg LJP; Ngcapu S
Front Immunol; 2021; 12():730986. PubMed ID: 34594336
[TBL] [Abstract][Full Text] [Related]
10. Gene Expression Profiling of Human Vaginal Cells In Vitro Discriminates Compounds with Pro-Inflammatory and Mucosa-Altering Properties: Novel Biomarkers for Preclinical Testing of HIV Microbicide Candidates.
Zalenskaya IA; Joseph T; Bavarva J; Yousefieh N; Jackson SS; Fashemi T; Yamamoto HS; Settlage R; Fichorova RN; Doncel GF
PLoS One; 2015; 10(6):e0128557. PubMed ID: 26052926
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the vaginal microflora in health and disease.
Datcu R
Dan Med J; 2014 Apr; 61(4):B4830. PubMed ID: 24814599
[TBL] [Abstract][Full Text] [Related]
12. Distinct Immune Responses Elicited From Cervicovaginal Epithelial Cells by Lactic Acid and Short Chain Fatty Acids Associated With Optimal and Non-optimal Vaginal Microbiota.
Delgado-Diaz DJ; Tyssen D; Hayward JA; Gugasyan R; Hearps AC; Tachedjian G
Front Cell Infect Microbiol; 2019; 9():446. PubMed ID: 31998660
[TBL] [Abstract][Full Text] [Related]
13. Atopobium vaginae triggers an innate immune response in an in vitro model of bacterial vaginosis.
Libby EK; Pascal KE; Mordechai E; Adelson ME; Trama JP
Microbes Infect; 2008 Apr; 10(4):439-46. PubMed ID: 18403235
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Lactobacillus crispatus isolates from Lactobacillus-dominated vaginal microbiomes with isolates from microbiomes containing bacterial vaginosis-associated bacteria.
Abdelmaksoud AA; Koparde VN; Sheth NU; Serrano MG; Glascock AL; Fettweis JM; Strauss JF; Buck GA; Jefferson KK
Microbiology (Reading); 2016 Mar; 162(3):466-475. PubMed ID: 26747455
[TBL] [Abstract][Full Text] [Related]
15. The anti-HIV microbicide candidate RC-101 inhibits pathogenic vaginal bacteria without harming endogenous flora or mucosa.
Eade CR; Cole AL; Diaz C; Rohan LC; Parniak MA; Marx P; Tarwater PM; Gupta P; Cole AM
Am J Reprod Immunol; 2013 Feb; 69(2):150-8. PubMed ID: 23167830
[TBL] [Abstract][Full Text] [Related]
16. Vaginal colonization of women after oral administration of Lactobacillus crispatus strain NTCVAG04 from the human microbiota.
DE Leo V; Lazzeri E; Governini L; Cuppone AM; Colombini L; Teodori L; Ciprandi G; Iannelli F; Pozzi G
Minerva Obstet Gynecol; 2023 Oct; 75(5):432-439. PubMed ID: 35686637
[TBL] [Abstract][Full Text] [Related]
17. Molecular Identification of Cervical Microbes in HIV-Negative and HIV-Positive Women in an African Setting Using a Customized Bacterial Vaginosis Microbial DNA Quantitative PCR (qPCR) Array.
Taku O; Onywera H; Mbulawa ZZA; Businge CB; Meiring TL; Williamson AL
Microbiol Spectr; 2022 Jun; 10(3):e0222921. PubMed ID: 35647888
[TBL] [Abstract][Full Text] [Related]
18. Cervicovaginal levels of lactoferrin, secretory leukocyte protease inhibitor, and RANTES and the effects of coexisting vaginoses in human immunodeficiency virus (HIV)-seronegative women with a high risk of heterosexual acquisition of HIV infection.
Novak RM; Donoval BA; Graham PJ; Boksa LA; Spear G; Hershow RC; Chen HY; Landay A
Clin Vaccine Immunol; 2007 Sep; 14(9):1102-7. PubMed ID: 17671228
[TBL] [Abstract][Full Text] [Related]
19. Probiotic Properties of Lactobacillus crispatus 2,029: Homeostatic Interaction with Cervicovaginal Epithelial Cells and Antagonistic Activity to Genitourinary Pathogens.
Abramov V; Khlebnikov V; Kosarev I; Bairamova G; Vasilenko R; Suzina N; Machulin A; Sakulin V; Kulikova N; Vasilenko N; Karlyshev A; Uversky V; Chikindas ML; Melnikov V
Probiotics Antimicrob Proteins; 2014 Dec; 6(3-4):165-76. PubMed ID: 25028263
[TBL] [Abstract][Full Text] [Related]
20. Bacterial colonization and beta defensins in the female genital tract in HIV infection.
Jiang W; Ghosh SK; Flyckt R; Kalinowska M; Starks D; Jurevic R; Weinberg A; Lederman MM; Rodriguez B
Curr HIV Res; 2012 Sep; 10(6):504-12. PubMed ID: 22716110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
